Notification of Transaction by PDMR

RNS Number : 3910U

Assura PLC

18 January 2017

 

18 January 2017

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company has been notified that in respect of the interim dividend for the 2016/17 financial year paid on 18 January 2017, the following PDMR acquired ordinary shares of 10 pence each in the Company through their participation in the Company's Scrip Dividend Alternative:

PDMR	Date Acquired	Number of shares acquired	Purchase price per Share
Simon Laffin	18 January 2017	35,593	£0.560

The Notification of Dealing Form for Mr Laffin can be found below.

This notification is made in accordance with the Market Abuse Regulation.

-ENDS-

Notification of dealing form

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Simon Laffin
2	Reason for the notification
a)	Position/status	Chairman
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Purchase of shares under the Scrip Dividend Alternative
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.560 GBP 35,593
d)	Aggregated information -     Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.560 GBP 35,593 £19,932.08 GBP
e)	Date of the transaction	18 January 2017
f)	Place of the transaction	XLON

Enquiries

Assura plc	Tel: [phone]
Orla Ball
Finsbury	Tel: [phone]
Gordon Simpson

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2016, Assura's property portfolio was valued at £1,227 million.  

Further information is available at www.assuraplc.com

 

END

 

 

DSHZDLFFDFFEBBV